The Bayes Pharma conference is dedicated since 2010 to advancing the application of Bayesian statistics within the biomedical and pharmaceutical sectors. Its primary objectives include promoting Bayesian methodologies in biomedical sciences, showcasing practical case studies across clinical and non-clinical environments, and updating participants on the latest methodological advancements in Bayesian statistics pertinent to medicine and public health. Additionally, the conference aims to provide statisticians with opportunities to adapt to the evolving landscape of the biopharmaceutical industry. The event spans three days, commencing with a training course focused in 2025 on Bayesian and Causal Networks for Clinical and Epidemiological Data. This is followed by two days filled with keynote presentations and contributed talks from experts in the field. The upcoming Bayes 2025 conference is scheduled for October 22-24, 2025, in Leiden, The Netherlands. Participants can anticipate a comprehensive program featuring training sessions, keynote addresses, and discussions on the latest applications of Bayesian statistics in the biomedical field. Organized by the Adolphe Quetelet Society, an official region of the International Biometric Society (IBS), the conference upholds the IBS’s commitment to scientific and ethical integrity. The conference is also sponsored by the American Statistical Society. It fosters an environment of respect and inclusivity, ensuring professional conduct among all attendees. For more details on registration, program schedules, and other pertinent information, interested individuals are encouraged to visit the official conference website.